There is no "Sleep" aisle on quick commerce — the category is scattered across supplement, wellness and personal-care shelves. This is what it looks like once you reassemble it SKU by SKU: what sells, which actives and formats win, which cities want which bottle, who owns the search bar, and where an entering brand has room to move.
Your instinct from Juices is right: every platform organises wellness its own way, and "Sleep" is not one of those ways. No platform carries a real Sleep category. Sleep products are filed under whatever broad supplement or personal-care shelf they physically resemble — so the only way to see Sleep is to classify it at the SKU level across every shelf it hides in. We did exactly that.
With no Sleep aisle, discovery happens through the search bar and molecule keywords — not category navigation. SEO on "sleep", "melatonin", "magnesium for sleep" is your shelf.
A magnesium lotion or pillow mist won't sit next to your gummy — it routes to Body Lotions / Home Fragrances. A cross-category sleep line is visible to the platform as three unrelated products.
Because everything is keyword-tagged at SKU level, a full sleep read — segment, format, price, brand, velocity — can be rebuilt and tracked over time. Coverage exists; structure doesn't.
Reassembled, the sleep shelf collapses onto two molecules. Melatonin and ingestible magnesium together carry roughly 95% of category value. Topical magnesium, botanical/ayurvedic sleep aids and aromatherapy each register, but only just — which is precisely where the open ground is.
Share of category offtake value across major platforms. Botanical actives are understated here because most are sold inside melatonin blends rather than as standalone products.
The mix tilts depending on where you stand. On Swiggy, melatonin leads (~58% vs 41% magnesium). On Blinkit, it inverts — magnesium edges ahead (~51% vs 34% melatonin), helped by pharmacy-style buyers and a stronger topical presence. A new brand's "primary active" decision is therefore also a platform decision.
The category lists ~50 distinct melatonin SKUs and ~80 magnesium SKUs — but fewer than two in five register meaningful sales. The shelf is crowded with launches that never found velocity. Listing is cheap; selling is not.
You named the sub-segments you care about. Here is each one as it actually reads on quick commerce today — size, who owns it, typical shelf price, and how contested it is. This is the "trending within the category" view you asked whether you could get. You can.
| Sub-segment | Presence | Leading brands | Typical shelf price | Read |
|---|---|---|---|---|
| Melatonin | Largest | Wellbeing Nutrition, Vicks ZzzQuil, What's Up Wellness, Plix, Ayuvya | ₹200–850 | Anchor of the category; format is the only real differentiator left. |
| Magnesium — ingestible | Co-leader | Wellbeing Nutrition, Carbamide Forte, Tata 1mg, Ace Blend | ₹350–1,250 | Dual-positioned (sleep + recovery); least branded, most premium. |
| Magnesium lotion (topical) | Emerging | Hoop, Be Bodywise, Femisafe, RAWRX, Therra | ₹350–520 | Punches above its weight on Blinkit; no clear leader — open. |
| Non-melatonin / botanical | Thin standalone | Zandu (ashwagandha), Happy Cultures, BeastLife blends | ₹300–800 | Ubiquitous as a blend ingredient, rare as a hero product — a gap. |
| Essential-oil / pillow mist | Nascent | Phool (sleep pillow mist, lavender oil) | ₹300–400 | A handful of SKUs, negligible offtake. Category-creation territory. |
| Roll-ons / inhalers | Effectively absent | — | — | No meaningful sleep-positioned presence on q-comm yet. Blank canvas. |
| Sleep tea | Negligible | TGL, Teabox (sleep/sweet-dreams blends) | ₹250+ | Lives in the tea aisle, not the sleep set; weak crossover. |
The headline most founders get wrong: gummies are the loud format, but on quick-commerce value the oral dissolving strip / melt leads — and it leads because one brand built its franchise on it. Format, more than molecule, is what separates the premium shelf from the value bin.
† Several gummy SKUs carry no "gummy" token in their title and fold into a value-tier mix; treat gummies as a popular but discount-led format rather than a value leader.
The melt/strip format sells a faster onset and no-water ritual — and commands the highest realised prices in the set (₹700–850 a pack). It is the format that let the category leader hold premium while the gummy field discounts against itself.
Premium strips and the leader's magnesium run on single-digit discounts; value gummies and me-too magnesium lean on 20–35% cuts to move. Discount depth is a clean tell for which brands have pull and which are buying the shelf.
Sleep on quick commerce is bimodal. There's an accessible band where the volume lives and a premium band where the value concentrates — with a thin, under-defended middle. That middle is a pricing entry point hiding in plain sight.
Roughly two-thirds of units, under half of value. This is melatonin gummies, effervescents and entry magnesium — high traffic, thin margin, heavy discounting. Easy to enter, hard to defend.
A fifth of units but ~46% of value. Premium magnesium glycinate and premium strips live here, on low discounts. This is where brand equity converts to rupees.
Just ~9% of value and volume — the thinnest band. A credibly-built product priced into this corridor faces the least direct crossfire.
The competitive truth depends entirely on which platform you read. Wellbeing Nutrition — the best-funded sleep-active D2C in India — is close to a monopoly where its distribution is deep, yet only first-among-equals where the field is open. For an entrant, that contrast is the whole strategy.
Brand value, indexed to leader = 100
Built on two engines: its melatonin Melts strips (the single top-selling SKU in the whole category) and a premium magnesium glycinate. Swiggy is, for now, a fortress.
Brand value, indexed to leader = 100
Here the leader holds barely a sixth of value. A magnesium specialist (Carbamide), a pharmacy brand (Tata 1mg) and two topical-magnesium upstarts all sit in striking distance. This is the open battlefield.
Wellbeing Nutrition: premium, format-first (Melts), well-funded. Sets the ceiling. Hard to beat on its own SKU; beatable on the shelves it under-serves.
Carbamide Forte, Tata 1mg, Ayuvya — dose-and-price players and platform-adjacent pharmacy brands. Strong on Blinkit, discount-reliant, low brand pull.
P&G's Vicks ZzzQuil is present but small — a melatonin-+-ashwagandha gummy leaning on "non-addictive". The brand most can name, not the one most buy.
For a launch, where you point distribution matters as much as what you sell. Sleep offtake concentrates hard in the metros, but the active mix, the price a city will bear, and how big a slice of the supplement basket sleep commands all shift street by street. The map below is relative — each city indexed to the biggest.
Delhi NCR and Bangalore are effectively tied at the top; together ~a third of category value, and with Mumbai + Hyderabad ~55%. The rest is a wide, shallow tail of cities each under ~5%.
The headline isn't just "go to metros" — it's that the same product won't lead in two cities. Bangalore, Pune and the northern tier-2 belt are melatonin-first; Chennai, Mumbai and Hyderabad lean magnesium. Delhi is the one balanced market.
Sleep is ~9–13% of the supplement basket across the metros — but it punches to 16–18% in tier-2 cities (Raipur, Kanpur, Bareilly). Smaller pies, but sleep is a bigger slice of them — real expansion optionality once a metro beachhead holds.
| City | Volume index | Active it reaches for | Realised price (ASP) | Sleep share of supplements |
|---|---|---|---|---|
| Delhi NCR | 100 | Balanced 51/44 | ₹621 · mid | ~13% (high) |
| Bangalore | 100 | Melatonin 59% | ₹735 · premium | ~9% |
| Mumbai | 54 | Magnesium 58% | ₹720 · premium | ~13% (high) |
| Hyderabad | 50 | Magnesium 55% | ₹772 · top | ~13% (high) |
| Pune | 27 | Melatonin 66% | ₹550 · value | — |
| Chennai | 13 | Magnesium 73% | ₹575 · value | — |
| Jaipur · Surat · Nagpur | ~10 | Melatonin 76–86% | ₹690–725 | — |
| Kolkata · Indore | ~8 | Topical-mag 7–8% | ₹583–731 | — |
Reading the shelf at the variant level — dose, format, flavour, pack — tells you where to spend design effort. Most of it converges on one conclusion: the category competes on format and price-per-dose, not on dose numbers, flavours or bundles. Several "obvious" levers are quietly empty.
The inverse relationship is the whole story: the format with the most value discounts the least (strips, ~5%), while the value formats buy their volume with 15–20% cuts. Discount depth is the cleanest read on which formats have real pull.
Where dose is stated, 10mg — the FSSAI ceiling — leads value, anchored by the premium strip. But ~45% of melatonin SKUs don't put a dose on the title at all. Brands compete on format and feel, not on a milligram number. Stating dose is a clarity play, not a winning one.
Per single dose, a melatonin strip runs ~₹24 versus a magnesium tablet at ~₹6 — roughly a 4× premium for the same active delivered in a faster, ritual-forward format. Format, not molecule, is where the margin is.
Essentially 100% of sales are single units. Multipacks, combos and subscription packs barely register — the market is trial-led and un-bundled. A "sleep routine" subscription is an open structural play.
Over 90% of SKUs don't surface a flavour in the name. Flavour is a value/gummy-tier embellishment, not a premium differentiator — worth doing, not worth leading on.
The one axis that consistently separates winners from the discount bin. Lead with a defensible format and a price-per-dose story; let dose, flavour and pack follow.
On quick commerce, with no Sleep aisle, the search box is the shelf — so who ranks for "sleep", "melatonin" and "magnesium" decides who gets bought. We pulled live search results for the head terms across the two biggest cities. The result reframes the whole competitive picture: the brand that owns ~three-quarters of sales holds only ~an eighth of search visibility.
Rank-weighted share of the top-12 organic+sponsored slots for head sleep terms, Delhi NCR + Bangalore. The leader holds ~12%; the top five ~40%. No one owns this.
Wellbeing Nutrition converts ~73% of sales from just ~12% of search presence — its franchise is brand-pull and repeat, not shelf domination. For an entrant that means the discovery surface is winnable even though the sales chart looks closed.
Sponsored placements take 19–25% of the top dozen results — heaviest on the generic term "sleep" (25%). There's a real ad-funded layer to clear, but four in five slots are still earned.
Be Bodywise and Plix rank top-five on almost zero ad spend — listing and review equity. ZzzQuil (71%), Optimum (79%), Arth (69%) rent their visibility. The gap between the two groups is the opportunity map.
Three moves fall straight out of this: (1) a precise long-tail term like "magnesium for sleep" is cheaper to own than the contested generic "sleep"; (2) earned rank is achievable — strong listings, ratings and velocity put Be Bodywise and Plix in the top five without buying it; (3) a modest ad budget can leapfrog onto a fragmented first page where the leader sits at ~12%. The shelf is rented, not owned — and rent is affordable here.
Live search-rank capture for the head terms across Delhi NCR + Bangalore (Blinkit). "Share of voice" weights higher ranks more; irrelevant cross-category results (e.g. a coffee brand surfacing for "sleep") are excluded from the brand chart.
Quick-commerce offtake tells you the shelf; outside evidence tells you the wind behind it — and the one regulatory fact that shapes every product decision.
of Indians get under 6 hours of uninterrupted sleep — up from 50% two years earlier.1
reported jump in sleep-gummy sales in a year; related searches up ~650%.2
melatonin is OTC under FSSAI as a nutraceutical — no prescription, capped per day.3
claim across nearly every brand: "non-habit-forming." Dependence anxiety is the category's core nerve.4
Melatonin sits on the food side of the line: FSSAI-regulated nutraceutical, ≤10mg/day, self-certified — so 5mg and 10mg products are compliant and ship today. That's why the shelf is crowded: anyone can make a legal melatonin gummy. A 2024 government panel is reviewing whether high-dose nutraceuticals should revert to drug oversight — a watch-item, not a wall.3,5
If the molecule is free to copy and the universal claim is "non-habit-forming," then the two defensible moves both point away from generic melatonin: build a format/brand moat, or build on non-melatonin actives (magnesium, ashwagandha, tagar, L-theanine) that answer the dependence fear head-on and sidestep the regulatory risk entirely.
Each of these is a place where demand signals exist but no brand has planted a flag — and where your supplement-plus-personal-care thesis has a structural advantage over the pure-pill players.
~2% of value nationally but already out-punching its size on Blinkit (Hoop, Be Bodywise) — and spiking to 7–8% in Kolkata and Indore. No leader, a real global trend, and it sidesteps melatonin's claim/regulatory questions. The most validated of the open lanes.
Ashwagandha / tagar / L-theanine exist everywhere as blend ingredients but almost nowhere as a hero product. A clean "natural, non-habit-forming" line directly answers the category's #1 anxiety.
Pillow mists, roll-ons and inhalers are nascent-to-absent. A pure-supplement brand can't credibly own bedtime ritual; a cross-category line can build a "shelf" no gummy brand can match.
The thinnest price band, on the most contested platform, where the leader is weakest. A credibly-premium product priced into this gap meets the least direct fire.
~100% of offtake is single units — multipacks, combos and sleep-routine subscriptions barely exist. Sleep is a nightly-use, high-repeat category mis-sold as one-off trial. A subscription/auto-replenish model is structurally unclaimed.
Read together, the shelf points to one posture: don't fight for the melatonin gummy — it's commoditised, discount-led and already owned. Win on format, on a second active, and on the personal-care ritual the incumbents can't assemble.
The leader didn't win on melatonin — it won on the melt/strip. Pick a format that carries a fast-onset, no-water ritual story and can hold price; let the molecule be table stakes. Gummies are the trap: loud, crowded, and discount-bound.
Magnesium is half the category yet barely branded, and topical magnesium is the single most validated whitespace: emerging offtake, no leader, no melatonin baggage. It's also the cleanest bridge between your supplement and personal-care ranges.
"Non-habit-forming" is everyone's claim — so out-claim it with substance: a botanical-led or magnesium-led hero that is structurally non-habit-forming, not just labelled so. This is the wedge against both melatonin anxiety and a tightening rulebook.
Swiggy is a Wellbeing fortress; Blinkit is a fragmented field where the leader holds barely a sixth. Enter where the air is open, price into the thin ₹600–900 corridor, build velocity and reviews, then take a proven SKU to Swiggy rather than launching into its monopoly.
Delhi NCR and Bangalore carry a third of demand and are the obvious beachhead — but the hero SKU should flex: a melatonin strip leads in Bangalore, Pune and the northern belt; a magnesium hero indexes far better in Chennai, Mumbai and Hyderabad. For a topical-magnesium test, the cheapest validation is Kolkata or Indore, where it already over-indexes.
The sales leader holds ~73% of offtake but only ~12% of search visibility, the top five just ~40%, and only ~1 in 5 slots is paid. Earn organic rank the way Be Bodywise and Plix do (listings, ratings, velocity), target the cheaper long-tail terms ("magnesium for sleep") before the contested generic "sleep", and use a modest ad budget to leapfrog onto a first page no one controls.
Dose numbers and flavours are largely absent from titles and don't move share; the premium strip earns a ~4× price-per-dose over a tablet on a ~5% discount while value gummies bleed 17–20%. Put the design effort into a format that holds price and a clear per-night value story.
Q-comm splinters a sleep line across supplement, lotion and fragrance aisles, so the brand must do the bundling: a coherent ritual (ingest + topical + ambient) marketed as one system. And since ~100% of sales today are single-unit trial, an auto-replenish subscription on a nightly-use product is open ground.